Nature BiotechnologyOvjeren akaunt

@NatureBiotech

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. Part of and .

NY/London/SF/LA/Heidelberg
Vrijeme pridruživanja: lipanj 2009.
Rođen/a 1. ožujka 1996.

Medijski sadržaj

  1. A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy

    , , i još njih 4
    Prikaži ovu nit
  2. Interleukin-23 engineering improves CAR T cell function in solid tumors

    , , i još njih 2
    Prikaži ovu nit
  3. Assessing the impact of generative AI on medicinal chemistry

    Prikaži ovu nit
  4. Experts in bioengineering exploring how to transform biomedical discovery will be at . Submit an abstract or register today for this unmissable event

  5. Biotechnology's link to the walking dead?

  6. The n-Lorem Foundation intends to form the connective tissue between patients, researchers, facilities and regulators needed to supply individual patients with RNA therapies designed to treat their own ultra-rare disease—at no cost

  7. Biotech millionaire funds free drugs for ultra-rare diseases -

    , , i još njih 2
  8. The biotech living and the walking dead

  9. Reading amino acids in a nanopore. In a step toward nanopore sequencing of proteins, an aerolysin pore discriminates many of the proteinogenic amino acids

    Prikaži ovu nit
  10. Derek Lowe on FDA's about-face approval of Sarepta’s 2nd drug for muscular dystrophy (golodirsen) just months after sending the company a complete response letter, which enumerated multiple problems

  11. Senator Bernie Sanders threatens to create legislation to break patents for price gouging after BioMarin contemplates pricing its gene therapy for hemophilia

  12. Fresh from the biotech pipeline. The biopharma industry’s regulatory successes are piling up at a breathless pace. The new cohort of drugs is also rich with novelty; more than half the class of 2019 are first-in-class therapies and vaccines

  13. Championing leadership development in healthcare

    , , i još njih 3
  14. Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring

    Prikaži ovu nit
  15. Identifying drug targets in tissues and whole blood with thermal-shift profiling

    i
    Prikaži ovu nit
  16. Geneticists solve a 15-year-old mystery surrounding a cluster of sudden deaths among Amish children, when they discovered they all were homozygous for a duplication in the RYR2 gene, which causes cardiac arrhythmic disorder

  17. Prikaži ovu nit
  18. We launch our podcast series talking with Stefan Schneeberger about the significance of Clavien and colleagues' paper describing a sophisticated perfusion machine able to keep human livers alive outside the body for one week

  19. Fresh from the biotech pipeline. The biopharma industry’s positive regulatory momentum carried on through 2019, despite a government shutdown, a data manipulation scandal around a high-profile approval, and months without permanent leadership at the FDA

  20. Traditional valuation approaches rarely take into account scientific considerations specific to a R&D project. A question-based approach using real options offers a solution

    , , i još njih 2
    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·